1,7-phenanthroline has been researched along with topotecan in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bhalla, K; Blaskovich, MA; Dunne, J; Gasparetto, M; Gentry, T; Haaland, P; Nimmanapalli, R; O'Bryan, E; Rizzieri, D; Sebti, S; Smith, C | 1 |
1 other study(ies) available for 1,7-phenanthroline and topotecan
Article | Year |
---|---|
Identification of compounds that enhance the anti-lymphoma activity of rituximab using flow cytometric high-content screening.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Aphidicolin; Apoptosis; Cell Cycle; Cell Line, Tumor; Drug Screening Assays, Antitumor; Flow Cytometry; Humans; Lymphoma; Phenanthrolines; Rituximab; Topotecan | 2004 |